Advertisement

Evaluation of Bedside Transfusion Practice: Benefits Vs Risks

  • R. S. Eisenstaedt
Chapter
Part of the Developments in Hematology and Immunology book series (DIHI, volume 31)

Abstract

Decisions about blood transfusion are made analogously to those of other medical intervention: benefits are compared to risks; safer alternatives to homologous blood, such as autologous blood or drugs as desmopressin or aprotinin that might reduce the risk of avoiding transfusion are assessed, as well. Such decisions may be analyzed on a global level by public health officials or outcomes assessment experts examining regional or national trends, mean number of transfusions per population, or rates of reported complications [1–4]. Transfusion decisions may also be reviewed by hospital committees studying variation in component use among physicians or the trigger at which different doctors are apt to transfuse patients [5, 6]. But most often transfusion decisions are made and ultimately assessed by doctors at the bedside, working with the short-term data at hand in their effort to interpret benefits and risks of blood administration. In this chapter, that bedside perspective of transfusion decision making will be examined and the biases that might distort the logic reviewed.

Keywords

Oxygen Delivery Fresh Freeze Plasma Platelet Transfusion Transfusion Practice Homologous Blood 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Stehling L, Ellison N, Gotta A, et al. A survey of transfusion practice among anesthesiologists. Vox Sang 1987;52:60–2.PubMedCrossRefGoogle Scholar
  2. 2.
    Surgenor D, Wallace E, Hale G, et al. Changing patterns of blood transfusions in four sets of United States hospitals, 1980 to 1985. Transfusion 1989;28:513–18.CrossRefGoogle Scholar
  3. 3.
    Goodnough LJ, Johnston MFM, Toy PTCY, et al. The variability of transfusion practice in coronary artery bypass surgery. JAMA 1991;265:86–90.PubMedCrossRefGoogle Scholar
  4. 4.
    Surgenor SM, Wallace EL, Hao SH, Chapman RH. Collection and transfusion of blood in the United States. N Engl J Med 1990;322:1646–51.PubMedCrossRefGoogle Scholar
  5. 5.
    Soumerai SB, Salem-Schatz S, Avorn J. A controlled trial of educational outreach to improve blood transfusion practices. JAMA 1993;270:961–66.PubMedCrossRefGoogle Scholar
  6. 6.
    McCullough J, Steeper TA, Connelly DP, et al. Platelet utilization in a university hospital. JAMA 1988;259:2414–18.PubMedCrossRefGoogle Scholar
  7. 7.
    Apstern CS, Dennis RL, Briggs L, et al. Effect of erythrocyte storage and oxyhemoglobin affinity changes on cardiac function. Am J Phys 1985;285:4508–15.Google Scholar
  8. 8.
    Sugarman HJ, Davidson DT,Vibal S, et al. The basis of defective oxygen delivery from stored blood. Surg Gynecol Obst 1970;131:733–41.Google Scholar
  9. 9.
    Stuart J, Nash GB. Red cell deformability and hematological disorders. Blood Rev 1990;4:141–47.PubMedCrossRefGoogle Scholar
  10. 10.
    Marik PE, Sibbald WJ. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 1993;269:3024–29.PubMedCrossRefGoogle Scholar
  11. 11.
    Ronco JJ, Phang PT, Walley KR, et al. Oxygen consumption is independent of changes in oxygen delivery and oxygen uptake in severe adult respiratory distress syndrome. Amer Rev Respir Dis 1991;143:1267–73.Google Scholar
  12. 12.
    Levine E, Rosen A, Sehgal L, et al. Physiologic effects of acute anemia: Implications for reduced transfusion trigger. Transfusion 1990;30:11–19.PubMedCrossRefGoogle Scholar
  13. 13.
    Woodson RD, Auerbach S. Effect of increased oxygen affinity and anemia on cardiac output and its distribution. J Appl Physiol 1982;53:1299–306.PubMedGoogle Scholar
  14. 14.
    Rodman T, Close HP, Purcell MK. The oxyhemoglobin dissociation curve in anemia. Ann Intern Med 1960;52:295–309.PubMedGoogle Scholar
  15. 15.
    Stehling L, Zander HL. Acute normovolemic hemodilution. Transfusion 1991;31:857–68.PubMedCrossRefGoogle Scholar
  16. 16.
    Chapler CK, Cain SM. The physiologic reserve in oxygen carrying capacity: Studies in experimental hemodilution. Can J Physiol Pharmacol 1986;64:7–12.PubMedCrossRefGoogle Scholar
  17. 17.
    Spence RK, Carson JA, Poses R, et al. Elective surgery without transfusion: Influence of preoperative hemoglobin level and blood loss on mortality. Am J Surg 1990; 159: 320–24.PubMedCrossRefGoogle Scholar
  18. 18.
    Fullerton WT, Turner AG. Exchange transfusion in treatment of severe anemia in pregnancy. Lancet 1922;i:75–78.Google Scholar
  19. 19.
    Kawaguchi A, Bergsland J, Subramanim S. Total bloodless open heart surgery in the pediatric age group. Circulation 1984;70(Suppl I):30–34.Google Scholar
  20. 20.
    Alexiu O, Mircea N, Balaban Furtunescu B. Gastrointestinal hemorrhage from peptic ulcer. An evaluation of bloodless transfusion and early surgery. Anaesthesia 1975;30: 609–16.PubMedCrossRefGoogle Scholar
  21. 21.
    Stehling L, Simon TL. The red blood cell transfusion trigger: Physiology and clinical studies. Arch Pathol Lab Med 1994;11:429–34.Google Scholar
  22. 22.
    Welch HG, Meehan KR, Goodnough, LT. Prudent strategies for elective red blood cell transfusion. Ann Int Med 1992;116:393–406.PubMedGoogle Scholar
  23. 23.
    NIH Consensus conference. Perioperative red cell transfusion. JAMA 1988;260: 2700–02.CrossRefGoogle Scholar
  24. 24.
    Stehling L, Zauder HL. How low can we go? Is there a way to know. Transfusion 1990;30:1–3.PubMedCrossRefGoogle Scholar
  25. 25.
    Eisenstaedt RS. Transfusion therapy: Blood components and transfusion complications. In: Rippe JM, Irwin RS, Alpert JS, Fink MP (eds). Intensive care medicine. Boston: Little Brown and Co 1991:1055–61.Google Scholar
  26. 26.
    Linden JV, Kaplan HS. Transfusion errors: Causes and effects. Trans Med Rev 1994;8:169–89.CrossRefGoogle Scholar
  27. 27.
    Tversky A, Kahneman D. Judgement under uncertainty: Heuristics and biases. Science 1984;185:1124–31.CrossRefGoogle Scholar
  28. 28.
    Blumberg N, Heal JM. Effects of transfusion on immune function: Cancer recurrence and infection. Arch Pathol Lab Med 1994;118:371–79.PubMedGoogle Scholar
  29. 29.
    Donahue JG, Munoz A, Ness PM, et al. The declining risk of post-transfusion hepatitis C infection. N Engl J Med 1992;327:369–73.PubMedCrossRefGoogle Scholar
  30. 30.
    Aubuchon JP. Minimizing donor exposure in hemotherapy. Arch Pathol Lab Med 1994;118:380–91.PubMedGoogle Scholar
  31. 31.
    Takahasi M, Yamada G, Miyamoto R, et al. Natural course of hepatitis C. Am J Gastroenterol 1993;88:240–43.Google Scholar
  32. 32.
    Seeff LB, Buskell-Boles Z, Wright EC, et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 1992;327:1906–11.PubMedCrossRefGoogle Scholar
  33. 33.
    National Blood Resource Education Program. Indications for the use of red blood cells, platelets, and fresh frozen plasma. In: Transfusion Alert. Publication no. 9–2974a, Bethesda.Google Scholar
  34. 34.
    Woodman RC, Harker LA. Bleeding complications associated with cardiopulmonary bypass. Blood 1990;76:1680–97.PubMedGoogle Scholar
  35. 35.
    Sethi GK, Copeland JG, Goldman S. Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting. J Am Col Card 1990; 15:15–20.CrossRefGoogle Scholar
  36. 36.
    Salzman EW, Weinstein MJ, Weintraub RM, et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. N Engl J Med 1986;314:1402–6.PubMedCrossRefGoogle Scholar
  37. 37.
    Royston D. High dose aprotinin therapy: A review of the first five years experience. J Cardiothorac Vase Anesth 1992;6:76–100.CrossRefGoogle Scholar
  38. 38.
    Goodnough LT, Johnston MFM, Toy PTCY, et al. The variability of transfusion practice in coronary artery bypass surgery. JAMA 1991;265:86–90.PubMedCrossRefGoogle Scholar
  39. 39.
    Consensus confemce. Platelet transfusion therapy. JAMA 1987;257:1777–80.CrossRefGoogle Scholar
  40. 40.
    Lind SE. The bleeding time does not predict surgical bleeding. Blood 1991;77:2547–52.PubMedGoogle Scholar
  41. 41.
    Schiffer CA. Prophylactic platelet transfusion. Transfusion 1992;32:295–98.PubMedCrossRefGoogle Scholar
  42. 42.
    Saarinen UM, Kehomak R, Siimes MA, Myllyla G. Effective prophylaxis against platelet refractioness in multitransfused patients by the use of leukocyte-free blood components. Blood 1990;75:512–17.PubMedGoogle Scholar
  43. 43.
    Tomasulo PA, Lenes BA. Platelet transfusion therapy. In: Hemostatic disorders and the blood bank. Arlington, VA: American Association of Blood Banks 1984:63–89.Google Scholar
  44. 44.
    Beutler E. Platelet transfusion: The 20,000/µL trigger. Blood 1993;81:1411–13.PubMedGoogle Scholar
  45. 45.
    Consensus conference. Fresh frozen plasma. Indications and risks. JAMA 1985;253: 551–53.CrossRefGoogle Scholar
  46. 46.
    Ewe K. Bleeding after liver biopsy does not correlate with indices of peripheral coagulation. Dig Disease and Sciences 1981;26:388–93.CrossRefGoogle Scholar
  47. 47.
    McVay PA, Toy PTCY. Lack of increased bleeding after paracentesis and thoracentesis for patients with mild coagulation abnormalities. Transfusion 1991;31:164–71.PubMedCrossRefGoogle Scholar
  48. 48.
    Eisenstaedt RS. Transfusion triggers: Development and implementation. In: Aubuchon JP, Issitt PD (eds). Limiting donor exposure in hemotherapy. Behtesda, MD: American Association of Blood Banks 1994:27–44.Google Scholar
  49. 49.
    Soumerai SB, Avorn J. Principles of education outreach (“academic detailing”) to improve clinical decision making. JAMA 1990;263:549–56.PubMedCrossRefGoogle Scholar
  50. 50.
    Greco PJ, Eisenberg JM. Changing physician’ practices. N Engl J Med 1993;329: 1271–74.PubMedCrossRefGoogle Scholar
  51. 51.
    Heaton WAL. Changing patterns of blood use. Transfusion 1994;34:365–67.PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • R. S. Eisenstaedt

There are no affiliations available

Personalised recommendations